Abstract Progressive supranuclear palsy is a rare and rapidly progressive neurodegenerative syndrome. Clinical manifestations are heterogeneous and include Parkinsonism, postural instability, oculomotor dysfunction and cognitive impairment, with 80% of patients progressing to dementia within 3 years. Cognitive impairme...
Timothy P. Siejka, K. Bertram, H. Butzkueven et al.· Movement Disorders Clinical...· 0 citations
OBJECTIVE
To identify actions of primary care physicians (PCPs) that influence referral to specialist assessment for dementia from the perspective of people with symptoms of dementia and/or their significant others.
DESIGN
A descriptive qualitative design was used, involving 33 semistructured interviews that explored...
Hannah Gulline, Sarah Carmody, Amelia Bevins et al.· Family Medicine and Communit...· 0 citations
Multiple plasma proteins are elevated in presymptomatic and symptomatic ADAD mutation carriers relative to non-carriers, and combining biomarkers may help in staging presymptomatic AD and optimise clinical trial inclusion.
C. Belder, A. Heslegrave, O. Swann et al.· Journal of Neurology Neurosu...· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.